The decrease in CarnoSyn ® beta-alanine royalty, licensing, and raw material sales revenue during the second quarter of fiscal 2025 was primarily due to a decrease in orders from existing customers.

Cardiovascular health supplements address global CVD prevalence, featuring Omega-3s, CoQ10, and plant sterols. Production spans the US, Europe, and A ...

The launch of a premier private label program this month promises to offer independent retailers a new advantage in the ...